Skip to main content

Analytics

By HIMSS TV | 09:50 am | May 26, 2020
CEO Dave Lareau explains how Medicomp made early coronavirus-specific changes to its database and AI engine as the pandemic took hold in February – and has continued to innovate since then.
By Mike Miliard | 04:14 pm | May 22, 2020
Working Well, designed to support evolving clinical protocols, enables contact tracing and can be configured to organizations' own specific back-to-work needs.
By HIMSS TV | 07:00 am | May 22, 2020
Dr. Nathalie Bloch of the ARC Innovation Center at Sheba Medical Center, Israel, discusses the use of AI in dealing with COVID-19 patients, among various other innovative tools, in this episode of The Alessi Agenda.
By Mike Miliard | 01:13 pm | May 21, 2020
The collaboration aims to help health systems manage resource allocation and offer situational awareness for facilities as they open up and reschedule delayed surgeries and other procedures.
By Kat Jercich | 11:27 am | May 21, 2020
By using real-world patient information, the agency hopes to research population health trends and medication efficacy.
By Kat Jercich | 01:25 pm | May 20, 2020
Billed by the software giant as its first industry-specific cloud product, the newly-launched platform is also aimed at enhancing patient engagement, improving provider communication and boosting analytics.
SPONSORED
By Qualtrics | Mike Miliard | 01:00 am | May 19, 2020
In the rapidly changing modern healthcare environment, it is no longer tenable to collect patient feedback in an old-fashioned manner.
By Nathan Eddy | 12:47 pm | May 15, 2020
The Center for Post-COVID Care will provide resources for patients recovering from the disease, while the new Institute for Health Equity Research will explore ways to reduce healthcare disparities.
By Dean Koh | 10:02 pm | May 14, 2020
The expansion consists of NVIDIA Clara Parabricks computational genomics software, disease detection AI models and NVIDIA Clara Guardian application framework.
By Kat Jercich | 01:03 pm | May 14, 2020
The New York-based company claims its platform can be used to more accurately monitor efficacy of immunotherapy.